Sells prescription devices for headache and fibromyalgia to healthcare systems, and handheld wellness and human-performance products to consumers and professional organizations.
10-K for FY2025, filed Mar 19, 2026gammaCore gammaCore, is a prescription, handheld, medical device that is FDA cleared for a variety of primary headache conditions.…View ↗
Quell Fibromyalgia is an FDA-authorized, prescription only, wearable neuromodulation device that helps reduce the symptoms of fibromyalgia…View ↗
We offer Truvaga handsets for the support of general health and wellbeing. Truvaga products are available direct-to-consumer at…View ↗
TAC-STIM is a non-prescription form of nVNS for human performance and has been developed in collaboration with the United States Department…View ↗
Our two largest customers by revenue are the United States Department of Veterans Affairs and United States Department of Defense, or VA…View ↗
Full year ended December 31, Channel: 2025 2024 United States - Rx $ 24,073 $ 19,307 TAC-STIM 422 1,197 Outside the United States 1,892…View ↗
Sells prescription medical devices and non-prescription wellness products at set per-unit prices; customers pay after the products ship.
10-K for FY2025, filed Mar 19, 2026Our business generates revenues from the sale of prescription medical devices and non-prescription wellness products in the United States…View ↗
The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is…View ↗
The transaction price is based on the consideration that the Company expects to receive in exchange for its products and includes the fixed…View ↗
$32M
10-K for FY2025, filed Mar 19, 2026
$32M ↗
The VA and NHS use prescription products under qualifying agreements; prescriptions are filled through specialty pharmacies or healthcare systems, or directly by electroCore. Consumers buy Truvaga online or through retail partners, while military and professional organizations buy TAC-STIM.
10-K for FY2025, filed Mar 19, 2026Our two largest customers by revenue are the United States Department of Veterans Affairs and United States Department of Defense, or VA…View ↗
gammaCore gammaCore, is a prescription, handheld, medical device that is FDA cleared for a variety of primary headache conditions.…View ↗
We sell our general wellness products direct-to-consumer through our ecommerce site, www.truvaga.com, and through select Truvaga retail and…View ↗
TAC-STIM is a non-prescription form of nVNS for human performance and has been developed in collaboration with the United States Department…View ↗
We sell the TAC-STIM handset for human performance to active-duty military and professional organizations.View ↗
10-K for FY2025, filed Mar 19, 2026
The United States Department of Veteran Affairs comprised 71.2% of our revenue during the year ended December 31, 2025. The majority of our…View ↗
No. It lost $14M in FY2025.
10-Q for Q3 FY2026, filed Nov 4, 2026
−$1.3MView ↗
8-K, filed Sep 9, 2026
On September 8, 2026, the Board of Directors (the “Board”) of electroCore, Inc. (the “Company”) appointed Joshua S. Lev, the Company’s…View ↗
8-K, filed Aug 6, 2026
Increasing 2026 revenue guidance to greater than 30% year-over-year growthView ↗
Growing. Revenue grew 5.9x in 4 years, from $5.5M in FY2021 to $32M in FY2025, about 56% a year.
Broader prescription lineup
The older report described gammaCore as its flagship prescription device; the latest report also includes Quell Fibromyalgia, a prescription device for fibromyalgia.
10-K for FY2022, filed Mar 8, 2023 10-K for FY2025, filed Mar 19, 2026Our flagship model, gammaCore Sapphire, is a prescription medical device currently FDA cleared for a variety of primary headache…View ↗
Quell Fibromyalgia is an FDA-authorized, prescription only, wearable neuromodulation device that helps reduce the symptoms of fibromyalgia…View ↗
Competes with CEFALY Technologies, Theranica Bioelectronics, eNeura, Alphabet, Amazon.com, Apple, and Samsung Electronics
10-K for FY2025, filed Mar 19, 2026Several neuromodulation devices have been marketed for the treatment of migraine, including CEFALY (sold by CEFALY Technologies sprl)…View ↗
Loading...